v3 Template
C

Cadenza Bio Inc.

Biotechnology ~340 employees
Founded
--
Employees (Est.)
~340
17 leaders known
Total Funding
$2.4M
Funding Rounds
1
Last Funding
2023-12-14

About Cadenza Bio Inc.

Cadenza Bio is a preclinical biotechnology company dedicated to developing novel small-molecule drugs for oral administration to treat demyelinating and inflammatory diseases. Their mission is to break the cycle of disease, halt progression, promote repair, and restore quality of life, empowering patients to regain control over their health.

Products & Services

Small-Molecule Drugs:A series of novel oral drugs targeting demyelinating and inflammatory diseases.

Specialties

Small-molecule drug development Treatment of demyelinating diseases Treatment of inflammatory diseases

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series Seed
T: -
FT: Series Seed 		A: 2440000
MR: -
FA: 2.44M
FAN: 2440000 		D: 2023-12-14
FD: 2023-12-14 		5 investors
Series Seed Latest
2023-12-14
$2.4M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Carol Curtis

CHIEF EXECUTIVE OFFICER, FOUNDER

E

Elaine Hamm

CHIEF OPERATING OFFICER, FOUNDER

D

David Martin

CHIEF DEVELOPMENT OFFICER

J

Jamie Boney-Montoya

DIRECTOR OF R&D

M

Mark Corrigan

SCIENTIFIC ADVISOR

M

Michael Panzara

SCIENTIFIC & MEDICAL ADVISOR

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Cadenza Bio Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~340 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro